XBIT
Income statement / Annual
Last year (2025), XBiotech Inc's total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2025, XBiotech Inc's net income was -$45.54 M.
See XBiotech Inc,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2025
|
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
| Period Ended |
12/31/2025 |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
| Operating Revenue |
$0.00 |
$0.00 |
$0.00 |
$4.01 M |
$18.39 M |
$44.00 M |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Cost of Revenue |
$1.69 M
|
$0.00
|
$0.00
|
$651.00 K
|
$5.82 M
|
$34.55 M
|
$2.36 M
|
$2.43 M
|
$1.48 M
|
$698.00 K
|
| Gross Profit |
-$1.69 M
|
$0.00
|
$0.00
|
$3.36 M
|
$12.57 M
|
$9.45 M
|
-$2.36 M
|
-$2.43 M
|
-$1.48 M
|
-$698.00 K
|
| Gross Profit Ratio |
0
|
0
|
0
|
0.84
|
0.68
|
0.21
|
0
|
0
|
0
|
0
|
| Research and Development Expenses |
$47.39 M
|
$37.76 M
|
$32.85 M
|
$31.54 M
|
$28.27 M
|
$9.53 M
|
$24.09 M
|
$15.73 M
|
$26.42 M
|
$42.49 M
|
| General & Administrative Expenses |
$8.30 M
|
$4.71 M
|
$4.66 M
|
$6.31 M
|
$9.39 M
|
$18.20 M
|
$0.00
|
$5.27 M
|
$7.64 M
|
$10.28 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$8.30 M
|
$4.71 M
|
$4.66 M
|
$6.31 M
|
$9.39 M
|
$18.20 M
|
$4.78 M
|
$5.27 M
|
$7.64 M
|
$10.28 M
|
| Other Expenses |
-$1.69 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$4.00 K
|
$0.00
|
$0.00
|
| Operating Expenses |
$54.00 M
|
$42.47 M
|
$37.51 M
|
$37.85 M
|
$37.66 M
|
$27.73 M
|
$28.87 M
|
$20.99 M
|
$34.06 M
|
$52.76 M
|
| Cost And Expenses |
$55.69 M
|
$42.47 M
|
$37.51 M
|
$38.50 M
|
$43.48 M
|
$62.27 M
|
$31.23 M
|
$20.99 M
|
$34.06 M
|
$52.76 M
|
| Interest Income |
$5.68 M
|
$9.81 M
|
$10.42 M
|
$3.82 M
|
$467.00 K
|
$2.46 M
|
$564.00 K
|
$400.00 K
|
$354.00 K
|
$49.00 K
|
| Interest Expense |
$88.00 K
|
$807.00 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Depreciation & Amortization |
$1.69 M
|
$1.75 M
|
$1.74 M
|
$2.61 M
|
$2.65 M
|
$2.24 M
|
$2.36 M
|
$2.43 M
|
$1.48 M
|
$698.00 K
|
| EBITDA |
-$54.00 M |
-$36.01 M |
-$22.57 M |
-$31.88 M |
-$22.43 M |
-$16.04 M |
$720.81 M |
-$18.71 M |
-$32.58 M |
-$52.06 M |
| EBITDA Ratio |
0
|
0
|
0
|
-7.95
|
-1.22
|
-0.36
|
0
|
0
|
0
|
0
|
| Operating Income Ratio |
0
|
0
|
0
|
-8.6
|
-1.36
|
-0.42
|
0
|
0
|
0
|
0
|
| Total Other Income/Expenses Net |
$10.38 M
|
$3.91 M
|
$13.20 M
|
$902.00 K
|
-$376.00 K
|
$5.45 M
|
$749.69 M
|
-$144.00 K
|
$909.00 K
|
$2.00 K
|
| Income Before Tax |
-$45.31 M
|
-$38.56 M
|
-$24.31 M
|
-$33.59 M
|
-$25.46 M
|
-$12.83 M
|
$718.45 M
|
-$21.14 M
|
-$33.15 M
|
-$52.76 M
|
| Income Before Tax Ratio |
0
|
0
|
0
|
-8.38
|
-1.38
|
-0.29
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
$235.00 K
|
-$32.00 K
|
$244.00 K
|
-$688.00 K
|
-$8.04 M
|
-$1.61 M
|
$49.82 M
|
-$144.00 K
|
$0.00
|
-$2.00 K
|
| Net Income |
-$45.54 M
|
-$38.53 M
|
-$24.56 M
|
-$32.90 M
|
-$17.41 M
|
-$11.22 M
|
$668.63 M
|
-$21.14 M
|
-$33.15 M
|
-$52.76 M
|
| Net Income Ratio |
0
|
0
|
0
|
-8.2
|
-0.95
|
-0.26
|
0
|
0
|
0
|
0
|
| EPS |
-1.49 |
-1.26 |
-0.81 |
-1.08 |
-0.58 |
-0.36 |
17.17 |
-0.59 |
-0.95 |
-1.63 |
| EPS Diluted |
-1.49 |
-1.26 |
-0.81 |
-1.08 |
-0.58 |
-0.36 |
14.44 |
-0.59 |
-0.95 |
-1.63 |
| Weighted Average Shares Out |
$30.49 M
|
$30.46 M
|
$30.32 M
|
$30.44 M
|
$30.04 M
|
$30.82 M
|
$38.95 M
|
$35.80 M
|
$34.88 M
|
$32.40 M
|
| Weighted Average Shares Out Diluted |
$30.49 M
|
$30.46 M
|
$30.44 M
|
$30.44 M
|
$30.04 M
|
$30.82 M
|
$46.32 M
|
$35.80 M
|
$34.88 M
|
$32.40 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
